Finland· FI-REL-REL47980
Seleeni Aguettant
A sodium selenite product containing sodium selenite anhydrous, registered in Finland by Laboratoire Aguettant. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Sodium selenite is registered in 7 of 19 countries.
Countries holding a registration under ATC A12CE02 (sodium selenite), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Sodium selenite · ATC A12CE02
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Sodium selenite anhydrous
- Manufacturer
- Laboratoire Aguettant
- Country
- Finland (FI)
- ATC code
- A12CE02
- ATC class
- Sodium selenite
- Defined daily dose
- 0.2 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for sodium selenite.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium selenite · interactions on record
5 records
- 1 severe
- 4 moderate
Most severe, free to view
- DimercaprolV03AB09severe
- TrientineA16AX12moderate
- EltrombopagB02BX05moderate
- LevofloxacinJ01MA12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium selenite in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumSelenium Aguettant 10 µg/mlLaboratoire Aguettant
- NetherlandsSelenase drank 100 µg, drank 50 µg/mlBiosyn Arzneimittel GmbH
- FranceSELENIUM OLIGOSOL 100 microgrammes/2 ml, solution buvable en ampouleLABCATAL
- GermanySelenLaboratoire Aguettant
- United KingdomAddaven concentrate for solution for infusion 10ml ampoulesFresenius Kabi Ltd
- Japan亜セレン酸ナトリウム藤本製薬
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Selen, Selen Fresenius
- Belgium · Selenium Aguettant
- Bulgaria · Cefasel
- Germany · Selen
- France · Oligosol, Selenium Laboratoire Aguettant
- United Kingdom (Northern Ireland) · Selenium Laboratoire Aguettant
- Greece · Motsalon, Sedynam
- Luxembourg · Oligosol, Selenium Aguettant
- Portugal · Selénio Aguettant
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6ad6d44d-f6b9-4fa3-9577-8820e6b2d023 GET /v1/drugs/6ad6d44d-f6b9-4fa3-9577-8820e6b2d023?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.2",
"form": "infuusioneste, liuos",
"route": null,
"ddd_unit": "mg",
"strength": "10 mikrog/ml",
"atc_label": "natriumseleniitti",
"ma_number": "33619",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL47980",
"authorised_at": "2016-03-24"
}See everything about sodium selenite.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.